November 8: Controversy Heats Up Over Pharmacy Benefit Manager DIR Fees

Pharmacy benefits managers (PBMs) are in hot water again if small and specialty pharmacies’ voices can be heard. Besides a litany of complaints from various pharmacy industry stakeholders about PBM operations and business tactics—from a lack of transparency to controlling formularies—now PBMs are being accused of retroactively applying direct and indirect remuneration fees (DIR) to pharmacies.

Read the full article on Managed Healthcare Executive here.

2017-11-08T09:02:30+00:00